🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/02/2006 | 33,00 | 33,50 | 32,90 | 33,16 | +0,39% | 1,83% | 449.000 |
| 03/02/2006 | 33,18 | 33,50 | 32,84 | 33,03 | -0,06% | 1,99% | 373.200 |
| 02/02/2006 | 33,53 | 33,68 | 32,45 | 33,05 | -1,17% | 3,67% | 748.400 |
| 01/02/2006 | 32,26 | 33,85 | 32,26 | 33,44 | +3,40% | 4,93% | 853.000 |
| 31/01/2006 | 31,98 | 32,41 | 31,98 | 32,34 | +0,89% | 1,34% | 401.600 |
| 30/01/2006 | 32,65 | 32,70 | 31,98 | 32,05 | -1,73% | 2,22% | 382.400 |
| 27/01/2006 | 32,55 | 33,15 | 32,18 | 32,62 | +0,22% | 2,98% | 671.200 |
| 26/01/2006 | 31,98 | 32,73 | 31,45 | 32,55 | +1,64% | 3,99% | 807.800 |
| 25/01/2006 | 32,50 | 32,95 | 31,91 | 32,02 | -1,36% | 3,18% | 682.200 |
| 24/01/2006 | 32,55 | 32,77 | 32,16 | 32,46 | -0,61% | 1,89% | 821.000 |
| 23/01/2006 | 33,43 | 33,43 | 32,11 | 32,66 | -1,54% | 3,95% | 1.008.400 |
| 20/01/2006 | 34,61 | 34,61 | 33,17 | 33,17 | -3,67% | 4,16% | 636.200 |
| 19/01/2006 | 34,45 | 34,64 | 34,03 | 34,44 | -0,17% | 1,77% | 618.200 |
| 18/01/2006 | 34,21 | 34,84 | 34,19 | 34,50 | +0,06% | 1,90% | 391.200 |
| 17/01/2006 | 34,41 | 34,54 | 34,25 | 34,48 | -0,43% | 0,83% | 557.000 |
| 13/01/2006 | 34,15 | 34,63 | 33,69 | 34,63 | +1,82% | 2,74% | 336.000 |
| 12/01/2006 | 34,26 | 34,26 | 33,82 | 34,01 | -1,43% | 1,27% | 510.800 |
| 11/01/2006 | 35,06 | 35,41 | 34,25 | 34,50 | -2,16% | 3,29% | 592.200 |
| 10/01/2006 | 34,68 | 35,30 | 34,68 | 35,26 | +1,25% | 1,79% | 401.200 |
| 09/01/2006 | 35,66 | 35,71 | 34,69 | 34,83 | -2,36% | 2,85% | 669.400 |
| 06/01/2006 | 35,10 | 35,67 | 34,82 | 35,67 | +2,13% | 2,42% | 484.200 |
| 05/01/2006 | 34,93 | 35,08 | 34,22 | 34,92 | +0,09% | 2,45% | 409.000 |
| 04/01/2006 | 33,98 | 35,00 | 33,98 | 34,89 | +1,88% | 3,00% | 691.000 |
| 03/01/2006 | 34,59 | 34,68 | 33,60 | 34,25 | -0,91% | 3,12% | 1.137.800 |
| 30/12/2005 | 34,64 | 34,77 | 34,21 | 34,56 | -0,69% | 1,62% | 327.400 |
| 29/12/2005 | 35,72 | 35,72 | 34,59 | 34,80 | -1,68% | 3,16% | 341.600 |
| 28/12/2005 | 35,49 | 35,77 | 35,39 | 35,40 | -0,44% | 1,07% | 260.600 |
| 27/12/2005 | 35,90 | 36,46 | 35,35 | 35,55 | -0,95% | 3,09% | 472.600 |
| 23/12/2005 | 36,41 | 36,49 | 35,80 | 35,89 | -0,82% | 1,90% | 464.200 |
| 22/12/2005 | 35,90 | 36,30 | 35,76 | 36,19 | +2,16% | 1,52% | 505.400 |